Healthy volunteers needed to test safety of experimental drug JZP047
NCT ID NCT07377539
First seen Jan 31, 2026 · Last updated May 14, 2026 · Updated 11 times
Summary
This early-stage study tests the safety and how the body processes a new drug called JZP047 in 86 healthy adults aged 18 to 55. Participants receive either the drug or a placebo, and some take the drug with or without food to see if meals affect absorption. The goal is to gather safety and drug-level information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Celerion, Inc.
RECRUITINGLincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.